# GSK plc: Form 4, filed Nov 7, 2017

- Company: [GSK plc](/companies/gsk.md) (CIK 1131399)
- Form: 4
- Filed: 2017-11-07
- Accepted by EDGAR: Nov 7, 2017, 19:42 ET
- Period: 2017-11-06
- Accession: 0000903423-17-000632
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1131399/000090342317000632/xslF345X03/glaxo-spero.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1131399/000090342317000632/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1131399/000090342317000632/xslF345X03/glaxo-spero.xml

Filed Nov 7, 2017.
Source: SEC EDGAR, the filing index for accession 0000903423-17-000632. Last ingested by Listed: Nov 2, 2026, 10:42 ET. No prices; not investment advice.
